T1	Participants 551 721	310 adults with AIDS who had recently recovered from an initial episode of PCP and had no treatment-limiting toxic effects of trimethoprim-sulfamethoxazole or pentamidine
T2	Participants 108 194	Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome
T3	Participants 249 285	Pneumocystis carinii pneumonia (PCP)
T4	Participants 334 382	in the acquired immunodeficiency syndrome (AIDS)
T5	Participants 723 768	All the patients were treated with zidovudine
T6	Participants 964 1022	The participants were followed for a median of 17.4 months
T7	Participants 2124 2171	patients with AIDS who are receiving zidovudine
